Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco Idzko

Showing results (11-20 of 189) with videos related to

Pageof 19
Sort By:
Immunology|June 12, 2012
Graft-versus-host disease reduces regulatory T-cell migration into the tumour tissueChristoph Dürr, Marie Follo, Marco Idzko, et al.
Blood|July 9, 2014
Extracellular nucleotide and nucleoside signaling in vascular and blood diseaseMarco Idzko, Davide Ferrari, Ann-Kathrin Riegel, et al.
Pulmonary Pharmacology & Therapeutics|September 19, 2020
Effectiveness of mepolizumab therapy in patients with severe eosinophilic asthma: Austrian real-life dataAndreas Renner, Katharina Marth, Karin Patocka, et al.
Allergy|June 12, 2020
Benralizumab rapidly improves asthma control in Austrian real-life severe eosinophilic asthmaticsAndreas Renner, Katharina Marth, Karin Patocka, et al.
Immunity, Inflammation and Disease|May 7, 2021
Dupilumab rapidly improves asthma control in predominantly anti-IL5/IL5R pretreated Austrian real-life severe asthmaticsAndreas Renner, Katharina Marth, Karin Patocka, et al.
The Journal of Investigative Dermatology|January 8, 2004
Tightening tight junctions with compression therapyBirgit Kahle, Marco Idzko, Johannes Norgauer, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|December 4, 2002
Treatment of nonhealing leg ulcers with fibrin-stabilizing factor XIII: a case reportTanja Hildenbrand, Marco Idzko, Elisabeth Panther, et al.
ERJ Open Research|December 1, 2020
COVID-19 in two severe asthmatics receiving benralizumab: busting the eosinophilia mythAndreas Renner, Katharina Marth, Karin Patocka, et al.
European Journal of Dermatology : EJD|March 1, 2003
Xeroderma pigmentosumJohannes Norgauer, Marco Idzko, Elisabeth Panther, et al.
Trends in Pharmacological Sciences|October 8, 2018
Purinergic Signaling: A New Pharmacological Target Against Viruses?Davide Ferrari, Marco Idzko, Tobias Müller, et al.
Pageof 19

Showing results (11-20 of 189) with videos related to

Sort By:
Pageof 19
Immunology|June 12, 2012
Graft-versus-host disease reduces regulatory T-cell migration into the tumour tissueChristoph Dürr, Marie Follo, Marco Idzko, et al.
Blood|July 9, 2014
Extracellular nucleotide and nucleoside signaling in vascular and blood diseaseMarco Idzko, Davide Ferrari, Ann-Kathrin Riegel, et al.
Pulmonary Pharmacology & Therapeutics|September 19, 2020
Effectiveness of mepolizumab therapy in patients with severe eosinophilic asthma: Austrian real-life dataAndreas Renner, Katharina Marth, Karin Patocka, et al.
Allergy|June 12, 2020
Benralizumab rapidly improves asthma control in Austrian real-life severe eosinophilic asthmaticsAndreas Renner, Katharina Marth, Karin Patocka, et al.
Immunity, Inflammation and Disease|May 7, 2021
Dupilumab rapidly improves asthma control in predominantly anti-IL5/IL5R pretreated Austrian real-life severe asthmaticsAndreas Renner, Katharina Marth, Karin Patocka, et al.
The Journal of Investigative Dermatology|January 8, 2004
Tightening tight junctions with compression therapyBirgit Kahle, Marco Idzko, Johannes Norgauer, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|December 4, 2002
Treatment of nonhealing leg ulcers with fibrin-stabilizing factor XIII: a case reportTanja Hildenbrand, Marco Idzko, Elisabeth Panther, et al.
ERJ Open Research|December 1, 2020
COVID-19 in two severe asthmatics receiving benralizumab: busting the eosinophilia mythAndreas Renner, Katharina Marth, Karin Patocka, et al.
European Journal of Dermatology : EJD|March 1, 2003
Xeroderma pigmentosumJohannes Norgauer, Marco Idzko, Elisabeth Panther, et al.
Trends in Pharmacological Sciences|October 8, 2018
Purinergic Signaling: A New Pharmacological Target Against Viruses?Davide Ferrari, Marco Idzko, Tobias Müller, et al.
Pageof 19